Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Eslam Saber Esmail"'
Autor:
Sherief Abd-Elsalam, Asem Elfert, Mai Khalaf, Mohamed Samir Abd El Ghafar, Ahmed Ghoneim, Shahinaz M. Shalaby, Eslam Saber Esmail, Mohamed Elbahnasawy, Hanan Soliman, Ghada N El-Sarnagawy, Ferial El-Kalla
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 21:1775-1780
In late 2019, SARS-COV-2 disease was firstly discovered in Wuhan, China and then it infected millions of people worldwide. Later, the World Health Organization (WHO) described COVID-19 as the first pandemic invading the world in the 21st century. The
Autor:
Shaimaa Soliman, Sahar M Hassany, Ossama A. Ahmed, Ehab F. Mostafa, Mohammed A Medhat, Mohamed Alboraie, Mohamed Samir Abd El Ghafar, Eslam Saber Esmail, Sherief Abd-Elsalam, Mai Khalaf
Publikováno v:
Biological Trace Element Research
No specific treatment for COVID-19 infection is available up till now, and there is a great urge for effective treatment to reduce morbidity and mortality during this pandemic. We aimed to evaluate the effect of combining chloroquine/hydroxychloroqui
Autor:
Ehab F. Abdo, Ghada N. Serangawy, Shaimaa Soliman, Sherief Abd-Elsalam, Mohamed Alboraie, Mai Khalaf, Ossama A. Ahmed, Mohammed A Medhat, Mohamed Samir Abd El Ghafar, Eslam Saber Esmail
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Am J Trop Med Hyg
Am J Trop Med Hyg
The COVID-19 pandemic is showing an exponential growth, mandating an urgent need to develop an effective treatment. Indeed, to date, a well-established therapy is still lacking. We aimed to evaluate the safety and efficacy of hydroxychloroquine (HCQ)
Autor:
Wasim Jafri, Lau Ing Soo, Shiv Kumar Sarin, Eslam Saber Esmail, J.S. Hwang, Tserendorj Chinbayar, Osamu Yokosuka, Arvinder S. Soin, Ian Homer Y. Cua, Chun-Yu Lin, Opass Putcharoen, Akash Shukla, Wan-Long Chuang, Sang Hoon Ahn, Ashok Choudhury, Oidov Baatarkhuu, Apichat Kaewdech, Teerha Piratvisuth, Xiaolong Qi, Chang Dong Yeo, Rino Alvani Gani, Mai Khalaf, Manoj K. Sharma, Sombat Treeprasertsuk, Shahinul Alam, Sherief Abd-Elsalam, Uzziel Romar Alonzo, Masao Omata, Vijay Pal Dara, Hery Djagat Purnomo, Diana A. Payawal, Jeong Ill Suh, Dong Ji, Hitendra K. Garg, Soo-Young Park, Salisa Wejnaruemarn, Mamun Al Mahtab, Ming-Hua Zheng, Kemal Fariz Kalista, Badamnachin Batsukh, Imelda Maria Loho, Tawesak Tanwandee, George K. K. Lau, Lovkesh Anand, S. G. Tan, Pravin Rathi, Jun Gi Park
Publikováno v:
Hepatology International
Background and Aims: COVID-19 is a dominant pulmonary disease, with multisystem involvement, depending upon co morbidities. Its profile in patients with pre-existing chronic liver disease (CLD) is largely unknown. We studied the liver injury patterns
Autor:
Raouf Gaber, Sherief Abd-Elsalam, Mai Khalaf, Eslam Saber Esmail, Ossama Ashraf Ahmed, Hatem Fawzy, Shaimaa Soliman, Kamal Okasha, Doaa El Amrousy, Ahmed M. Ghoneim
Publikováno v:
The Open Ophthalmology Journal. 16
Background: The aim of the work was to evaluate the ocular manifestations in the patients with COVID-19 and its role in the prediction of the course and the outcome of the disease. Methods: This retrospective study was conducted at two tertiary refer
Autor:
Shaimaa Soliman, Gamal Esmat, Mohamed Alboraie, Mohamed Samir Abd El Ghafar, Maii Atef Shams Eldeen, Eslam Saber Esmail, Haidi Karam-Allah Ramadan, Ehab F. Moustafa, Sherief Abd-Elsalam, Ahmed Cordie, Sahar M Hassany, Rasha A. Abdel Noor, Rehab Badawi, Mai Khalaf, Mohammed A Medhat, Mohamed Elbahnasawy
Publikováno v:
Journal of Medical Virology
Researchers around the world are working at record speed to find the best ways to treat and prevent coronavirus disease 2019 (COVID‐19). This study aimed to evaluate the efficacy of ivermectin for the treatment of hospitalized mild to moderate COVI
Autor:
Dalia E. El-Sharawy, Shaimaa Soliman, Abdelrahman Kobtan, Dina Abdelhai, Eslam Saber Esmail, Sherief Abd-Elsalam, Ferial El-Kalla, Mohammed Elhendawy, Maha M Hagras, Mai Khalaf
Publikováno v:
Endocrine, metabolicimmune disorders drug targets. 22(6)
Background & Aim: COVID-19 is a worldwide pandemic with high rates of morbidity and mortality, and an uncertain prognosis leading to an increased risk of infection in health providers and limited hospital care capacities. In this study, we have propo
Autor:
Osamu Yokosuka, Ian Homer Y. Cua, J.S. Hwang, Lovkesh Anand, Ashok Choudhury, Apasl Covid Task Force, S. G. Tan, Arvinder S. Soin, Rino Alvani Gani, Uzziel Romar Alonzo, Masao Omata, Ming-Hua Zheng, Salisa Wejnaruemarn, George K. K. Lau, Mamun Al Mahtab, Soo-Young Park, Dong Ji, Badamnachin Batsukh, Opass Putcharoen, Chang Dong Yeo, Shahinul Alam, Kemal Fariz Kalista, Eslam Saber Esmail, Tawesak Tanwandee, Manoj K. Sharma, Pravin Rathi, Akash Shukla, Tserendorj Chinbayar, Wasim Jafri, Lau Ing Soo, Chun-Yu Lin, Wan-Long Chuang, Mai Khalaf, Hitendra Garg, Xiaolong Qi, Hery Djagat Purnomo, Vijay Pal Dara, Sang Hoon Ahn, Jeong Ill Suh, Apichat Kaewdech, Teerha Piratvisuth, Sombat Treeprasertsuk, D.A. Payawal, Sherief Abd-Elsalam, Shiv Kumar Sarin, Apasl Covid Liver Injury Spectrum Study, Oidov Baatarkhuu, Imelda Maria Loho
Publikováno v:
SSRN Electronic Journal.
Background and Aims: COVID-19 is a dominant pulmonary disease, with multisystem involvement, depending upon co morbidities. Its profile in patients with pre-existing chronic liver disease (CLD) is largely unknown. We studied the liver injury patterns
Autor:
Eslam Saber Esmail, Reem Ezzat Mahdy, Mohamed El Kassas, Amr El-Badry, Asem Elfert, Fathia Assal, Sabry Abou-Saif
Publikováno v:
Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology. 18(1)
Background and study aims Splenectomy has been associated with high perioperative morbidity and mortality. Partial splenic artery embolisation (PSE) was found to be an effective and safer method but with numerous complications. Local thermal ablative
Publikováno v:
Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology. 17(3)